Strategic Blueprint, LLC Abbott Laboratories Transaction History

Strategic Blueprint, LLC

$1.38 Billion
Q2 2024

A detailed history of Strategic Blueprint, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Strategic Blueprint, LLC holds 5,097 shares of ABT stock, worth $572,087. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,097

Previous 4,863 4.81%

Holding current value

$572,087

Previous $552,000 4.17%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$100.73 - $112.44 $23,570 - $26,310	234 Added 4.81%	5,097 $529,000
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $395,586 - $436,907	-3,612 Reduced 42.62%	4,863 $552,000
Q4 2023 Jan 25, 2024	BUY	$90.19 - $110.4 $21,645 - $26,496	240 Added 2.91%	8,475 $932,000
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $27,321 - $32,781	286 Added 3.6%	8,235 $797,000
Q2 2023 Oct 18, 2023	SELL	$100.78 - $112.29 $27,009 - $30,093	-268 Reduced 3.26%	7,949 $866,000
Q1 2023 Apr 28, 2023	SELL	$96.86 - $114.01 $18,306 - $21,547	-189 Reduced 2.25%	8,217 $832,000
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $451,059 - $529,162	-4,745 Reduced 36.08%	8,406 $0
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $67,925 - $78,645	702 Added 5.64%	13,151 $1.27 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $16,127 - $19,492	158 Added 1.29%	12,449 $1.35 Million
Q1 2022 Aug 12, 2022	SELL	$114.02 - $139.04 $106,608 - $130,002	-935 Reduced 7.07%	12,291 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $95,312 - $116,704	825 Added 6.65%	13,226 $1.86 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $1.27 Million - $1.4 Million	-10,877 Reduced 46.73%	12,401 $1.47 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $1.17 Million - $1.38 Million	-11,070 Reduced 32.23%	23,278 $2.7 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $187,966 - $221,453	1,727 Added 5.29%	34,348 $4.12 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $1.61 Million - $1.76 Million	-15,354 Reduced 32.0%	32,621 $3.57 Million
Q3 2020 Oct 27, 2020	BUY	$91.64 - $111.29 $1.22 Million - $1.48 Million	13,298 Added 38.35%	47,975 $5.22 Million
Q2 2020 Jul 20, 2020	BUY	$76.57 - $98.0 $816,465 - $1.04 Million	10,663 Added 44.4%	34,677 $3.17 Million
Q1 2020 Apr 20, 2020	BUY	$62.82 - $91.86 $23,620 - $34,539	376 Added 1.59%	24,014 $1.9 Million
Q4 2019 Jan 10, 2020	SELL	$78.51 - $87.4 $28,813 - $32,075	-367 Reduced 1.53%	23,638 $2.05 Million
Q3 2019 Oct 16, 2019	BUY	$81.84 - $88.74 $1.7 Million - $1.84 Million	20,775 Added 643.19%	24,005 $2.01 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $211,758 - $239,892	3,230 New	3,230 $234,000

Others Institutions Holding ABT

# of Institutions

3,138

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.

Account

Strategic Blueprint, LLC Abbott Laboratories Transaction History